Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Closes $600M Offering of Convertible Notes

NEW YORK (GenomeWeb News) - Beckman Coulter said it is closing its offering of $600 million in convertible senior notes that it announced last week.
 
The company said the closing satisfied one condition of the offer, which allowed for the sale of notes that pay 2.5 percent semiannually and occasionally at the beginning of a six-month period December 2012, and are due in 2036.
 
Beckman offered an initial $525 million and investors took a $75 million option, the company said.
 
The tender offering closes Tuesday, December 19 at 5:00 EST, unless the company announces otherwise.
 
Beckman said it will use the part of the cash to resolve outstanding debts and fund R&D efforts, including a molecular diagnostics project.  
The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.